Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study

被引：0
|
作者：
Sriphoosanaphan, Supachaya [1 ,2 ,3 ]
Suksawatamnuay, Sirinporn [1 ,2 ,3 ]
Srisoonthorn, Nunthiya [2 ]
Siripon, Nipaporn [2 ]
Thaimai, Panarat [1 ]
Makhasen, Wanwisar [2 ]
Mungnamtrakul, Nawakodchamon [2 ]
Thanapirom, Kessarin [1 ,2 ,3 ]
Nonthasoot, Bunthoon [4 ]
Hansasuta, Pokrath [5 ,6 ]
Komolmit, Piyawat [1 ,2 ,3 ]
机构：
[1] Chulalongkorn Univ, Dept Med, Fac Med, Div Gastroenterol, Bangkok, Thailand
[2] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Ctr Excellence Liver Dis, Bangkok, Thailand
[3] Chulalongkorn Univ, Liver Fibrosis & Cirrhosis Res Unit, Bangkok, Thailand
[4] Chulalongkorn Univ, Fac Med, Dept Surg, Bangkok, Thailand
[5] Chulalongkorn Univ, Fac Med, Dept Microbiol, Div Virol, Bangkok, Thailand
[6] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT238
引用
收藏
页码：S772 / S772
页数：1
相关论文
共 50 条
  • [1] IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
    Sriphoosanaphan, Supachaya
    Suksawatamnuay, Sirinporn
    Srisoonthorn, Nunthiya
    Siripon, Nipaporn
    Thaimai, Panarat
    Makhasen, Wanwisar
    Mungnamtrakul, Nawakodchamon
    Thanapirom, Kessarin
    Nonthasoot, Bunthoon
    Hansasuta, Pokrath
    Komolmit, Piyawat
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1252 - S1252
  • [2] Immunogenicity, Immune Dynamics, and Subsequent Response to the Booster Dose of Heterologous versus Homologous Prime-Boost Regimens with Adenoviral Vector and mRNA SARS-CoV-2 Vaccine among Liver Transplant Recipients: A Prospective Study
    Sriphoosanaphan, Supachaya
    Suksawatamnuay, Sirinporn
    Srisoonthorn, Nunthiya
    Siripon, Nipaporn
    Thaimai, Panarat
    Ananchuensook, Prooksa
    Thanapirom, Kessarin
    Nonthasoot, Bunthoon
    Hansasuta, Pokrath
    Komolmit, Piyawat
    [J]. VACCINES, 2022, 10 (12)
  • [3] Immunogenicity and safety of heterologous versus homologous prime-boost schedules with inactivated and adenoviral vectored SARS-CoV-2 vaccines - A prospective multi-center study
    Phuensan, Pawat
    Sirimongkolkasem, Jarongkorn
    Tantawichien, Terapong
    Phannajit, Jeerath
    Kerr, Stephen J.
    Hansasuta, Pokrath
    Chantharit, Prawat
    Wongsa, Adisorn
    Fuengfoo, Pusit
    Chittinandana, Anutra
    Vareesangthip, Kriengsak
    Chayakulkeeree, Methee
    Jangsirikul, Sureeporn
    Schmidt, Araya
    Wanvimonsuk, Kanyika
    Winichakoon, Poramed
    Kajeekul, Rattagan
    Prayoonwiwat, Wichai
    Rerknimitr, Rungsun
    [J]. HELIYON, 2024, 10 (01)
  • [4] Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
    Jingjing Lv
    Hui Wu
    Junjie Xu
    Jiaye Liu
    [J]. Infectious Diseases of Poverty, 11
  • [5] Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
    Lv, Jingjing
    Wu, Hui
    Xu, Junjie
    Liu, Jiaye
    [J]. INFECTIOUS DISEASES OF POVERTY, 2022, 11 (01)
  • [6] Immunogenicity of homologous versus heterologous prime-boost vaccination regimens against SARS-COV-2 in people living with HIV in Argentina: a pilot study
    Mauas, R.
    Cecchini, D.
    Uruena, A.
    Strada, M.
    Arietti, S.
    Cassetti, I.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 215 - 215
  • [7] Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients
    Chu, Chang
    Schoenbrunn, Anne
    Fischer, Dorothea
    Liu, Yvonne
    Hocher, Johann-Georg
    Weinerth, Jutta
    Klemm, Kristin
    von Baehr, Volker
    Kraemer, Bernhard K.
    Elitok, Saban
    Hocher, Berthold
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
    Liu, Xinxue
    Shaw, Robert H.
    Stuart, Arabella S. V.
    Greenland, Melanie
    Aley, Parvinder K.
    Andrews, Nick J.
    Cameron, J. Claire
    Charlton, Sue
    Clutterbuck, Elizabeth A.
    Collins, Andrea M.
    Dinesh, Tanya
    England, Anna
    Faust, Saul N.
    Ferreira, Daniela M.
    Finn, Adam
    Green, Christopher A.
    Hallis, Bassam
    Heath, Paul T.
    Hill, Helen
    Lambe, Teresa
    Lazarus, Rajeka
    Libri, Vincenzo
    Long, Fei
    Mujadidi, Yama F.
    Plested, Emma L.
    Provstgaard-Morys, Samuel
    Ramasamy, Maheshi N.
    Ramsay, Mary
    Read, Robert C.
    Robinson, Hannah
    Singh, Nisha
    Turner, David P. J.
    Turner, Paul J.
    Walker, Laura L.
    White, Rachel
    Nguyen-Van-Tam, Jonathan S.
    Snape, Matthew D.
    [J]. LANCET, 2021, 398 (10303): : 856 - 869
  • [9] Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients
    Prayongrat, Anussara
    Noppaving, Patjaya
    Chobarporn, Thitiporn
    Sudhinaraset, Natthinee
    Teeyapun, Nattaya
    Pakvisal, Nussara
    Jantarabenjakul, Watsamon
    Sophonphan, Jiratchaya
    Lertbutsayanukul, Chawalit
    Poovorawan, Yong
    [J]. VACCINES, 2023, 11 (07)
  • [10] Immunogenicity and Safety Outcome of Homologous and Heterologous Prime-Boost of Inactivated Vaccine and Replication-Defective Viral Vectors Vaccine Against SARS-CoV-2 Among Hemodialysis Patients
    Narongkiatikhun, Phoom
    Ophascharoensuk, Vuddhidej
    Noppakun, Kajohnsak
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 313 - 314
12345